中文

U.S. Stocks · Health Care · Free Data Page

Revolution Medicines, Inc. RVMD

Revolution Medicines, Inc.: FY2025 revenue $0; net income -$1.13B; 2 alerts, 0 watch items out of 17 risk checks.
Close Price$200.15Day +4.09%Market Cap$43.29BP/E—Negative earningsP/B26.54xROE (FY2025)-58.1%Avg. equity

Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for Revolution Medicines, Inc.?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2018–2025

Key Multi-Year Facts

  • Net income was negative in FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)0.030.040.010.000.00
YoY-31.6%20.4%-67.3%-100.0%—
Net Income (USD B)-0.19-0.25-0.44-0.60-1.13
Operating Cash Flow (USD B)-0.15-0.22-0.35-0.56-0.90
ROE-34.7%-38.7%-34.7%-29.3%-58.1%
Net Margin-636.3%-703.8%-3765.1%——
Debt-to-Assets18.3%15.6%11.4%11.5%30.7%
Show all 8 fiscal years
Fiscal Year20182019202020212022202320242025
Revenue (USD B)0.020.050.040.030.040.010.000.00
YoY—148.2%-14.1%-31.6%20.4%-67.3%-100.0%—
Net Income (USD B)-0.04-0.05-0.11-0.19-0.25-0.44-0.60-1.13
Operating Cash Flow (USD B)0.00-0.05-0.10-0.15-0.22-0.35-0.56-0.90
ROE——-22.8%-34.7%-38.7%-34.7%-29.3%-58.1%
Net Margin-207.2%-95.2%-251.6%-636.3%-703.8%-3765.1%——
Debt-to-Assets—30.8%16.3%18.3%15.6%11.4%11.5%30.7%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-10

Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).

2Alert 0Watch 10Pass 5N/A

Items Flagged for Review

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Net LossesGoing Concern

    FY2025 (2025-12-31) $-1.13B, FY2024 (2024-12-31) $-0.60B

    FY2025 (ended 2025-12-31)

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?

Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.